Optimal diagnostic method using multidetector-row computed tomography for predicting lymph node metastasis in colorectal cancer.


Journal

World journal of surgical oncology
ISSN: 1477-7819
Titre abrégé: World J Surg Oncol
Pays: England
ID NLM: 101170544

Informations de publication

Date de publication:
22 Feb 2019
Historique:
received: 14 12 2018
accepted: 15 02 2019
entrez: 24 2 2019
pubmed: 24 2 2019
medline: 6 4 2019
Statut: epublish

Résumé

Prediction of nodal involvement in colorectal cancer is an important aspect of preoperative workup to determine the necessity of preoperative treatment and the adequate extent of lymphadenectomy during surgery. This study aimed to investigate newer multidetector-row computed tomography (MDCT) findings for better predicting lymph node (LN) metastasis in colorectal cancer. Seventy patients were enrolled in this study; all underwent MDCT prior to surgery and upfront curative resection for colorectal cancer. LNs with a short-axis diameter (SAD) ≥ 4 mm were identified on MDCT images, and the following measures were recorded by two radiologists independently: two-dimensional (2D) SAD, 2D long-axis diameter (LAD), 2D ratio of SAD to LAD, 2D CT attenuation value, three-dimensional (3D) SAD, 3D LAD, 3D SAD to LAD ratio, 3D CT attenuation value, LN volume, and presence of extranodal neoplastic spread (ENS), as defined by indistinct nodal margin, irregular capsular enhancement, or infiltration into adjacent structures. Forty-six patients presented 173 LNs with a SAD ≥ 4 mm, while 24 patients exhibited pathologically confirmed LN metastases. Receiver operating characteristic analysis revealed that 2D LAD was the most sensitive measure for LN metastases with an area under the curve of 0.752 (cut-off value, 7.05 mm). When combined with CT findings indicating ENS, 2D LAD (> or ≤ 7 mm) showed enhanced predictive power for LN metastases (area under the curve, 0.846; p < 0.001). LAD in axial MDCT imaging is the most sensitive measure for predicting colorectal LN metastases, especially when MDCT findings of ENS are observed.

Sections du résumé

BACKGROUND BACKGROUND
Prediction of nodal involvement in colorectal cancer is an important aspect of preoperative workup to determine the necessity of preoperative treatment and the adequate extent of lymphadenectomy during surgery. This study aimed to investigate newer multidetector-row computed tomography (MDCT) findings for better predicting lymph node (LN) metastasis in colorectal cancer.
METHODS METHODS
Seventy patients were enrolled in this study; all underwent MDCT prior to surgery and upfront curative resection for colorectal cancer. LNs with a short-axis diameter (SAD) ≥ 4 mm were identified on MDCT images, and the following measures were recorded by two radiologists independently: two-dimensional (2D) SAD, 2D long-axis diameter (LAD), 2D ratio of SAD to LAD, 2D CT attenuation value, three-dimensional (3D) SAD, 3D LAD, 3D SAD to LAD ratio, 3D CT attenuation value, LN volume, and presence of extranodal neoplastic spread (ENS), as defined by indistinct nodal margin, irregular capsular enhancement, or infiltration into adjacent structures.
RESULTS RESULTS
Forty-six patients presented 173 LNs with a SAD ≥ 4 mm, while 24 patients exhibited pathologically confirmed LN metastases. Receiver operating characteristic analysis revealed that 2D LAD was the most sensitive measure for LN metastases with an area under the curve of 0.752 (cut-off value, 7.05 mm). When combined with CT findings indicating ENS, 2D LAD (> or ≤ 7 mm) showed enhanced predictive power for LN metastases (area under the curve, 0.846; p < 0.001).
CONCLUSIONS CONCLUSIONS
LAD in axial MDCT imaging is the most sensitive measure for predicting colorectal LN metastases, especially when MDCT findings of ENS are observed.

Identifiants

pubmed: 30795767
doi: 10.1186/s12957-019-1583-y
pii: 10.1186/s12957-019-1583-y
pmc: PMC6387477
doi:

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

39

Références

Clin Colorectal Cancer. 2003 May;3(1):19-33
pubmed: 12777189
Eur J Radiol. 2004 Dec;52(3):264-70
pubmed: 15544904
J Comput Assist Tomogr. 2007 Nov-Dec;31(6):831-9
pubmed: 18043344
Colorectal Dis. 2009 May;11(4):354-64; discussion 364-5
pubmed: 19016817
J Clin Oncol. 2009 Nov 1;27(31):5124-30
pubmed: 19770376
Clin Radiol. 2010 Sep;65(9):708-19
pubmed: 20696298
Br J Surg. 2011 Dec;98(12):1798-804
pubmed: 21928408
Eur J Radiol. 1990 Sep-Oct;11(2):150-3
pubmed: 2253638
Lancet. 1986 Jun 28;1(8496):1479-82
pubmed: 2425199
Eur J Surg Oncol. 2014 Dec;40(12):1777-81
pubmed: 25260599
Int J Clin Oncol. 2015 Apr;20(2):207-39
pubmed: 25782566
Cancer Imaging. 2017 Jan 19;17(1):3
pubmed: 28103922
AJR Am J Roentgenol. 1988 Feb;150(2):301-6
pubmed: 3257314
AJR Am J Roentgenol. 1998 Jun;170(6):1439-43
pubmed: 9609150
Radiologe. 1998 Dec;38(12):1077-82
pubmed: 9931984
Eur Radiol. 1999;9(1):78-84
pubmed: 9933385

Auteurs

Tsutomu Kumamoto (T)

Department of Gastrointestinal Surgery, JR Tokyo General Hospital, Yoyogi 2-1-3, Shibuya-ku, Tokyo, Japan. k-s-tomu@amber.plala.or.jp.
Present Address: Department of Surgery, Hyogo College of Medicine, Mukogawa-cho 1-1, Nishinomiya, Hyogo, 663-8501, Japan. k-s-tomu@amber.plala.or.jp.

Junichi Shindoh (J)

Department of Gastroenterological Surgery, Toranomon Hospital, Tranomon 2-2-2, Minato-ku, Tokyo, Japan.

Hideaki Mita (H)

Department of Gastrointestinal Surgery, JR Tokyo General Hospital, Yoyogi 2-1-3, Shibuya-ku, Tokyo, Japan.

Yuriko Fujii (Y)

Department of Radiology, JR Tokyo General Hospital, Yoyogi 2-1-3, Shibuya-ku, Tokyo, Japan.

Yuichiro Mihara (Y)

Department of Gastrointestinal Surgery, JR Tokyo General Hospital, Yoyogi 2-1-3, Shibuya-ku, Tokyo, Japan.

Michiro Takahashi (M)

Department of Gastrointestinal Surgery, JR Tokyo General Hospital, Yoyogi 2-1-3, Shibuya-ku, Tokyo, Japan.

Nobuyuki Takemura (N)

Department of Gastrointestinal Surgery, JR Tokyo General Hospital, Yoyogi 2-1-3, Shibuya-ku, Tokyo, Japan.

Takako Shirakawa (T)

Department of Radiology, JR Tokyo General Hospital, Yoyogi 2-1-3, Shibuya-ku, Tokyo, Japan.

Hisashi Shinohara (H)

Present Address: Department of Surgery, Hyogo College of Medicine, Mukogawa-cho 1-1, Nishinomiya, Hyogo, 663-8501, Japan.

Hiroya Kuroyanagi (H)

Department of Gastroenterological Surgery, Toranomon Hospital, Tranomon 2-2-2, Minato-ku, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH